A cancer category in which a HER2-positive subgroup may define a distinct therapeutic vulnerability.
Each line below is retained only when a VOCE publication or formal research record supports the relationship.
HER2 defines a targetable subgroup within Biliary tract cancer.
A descriptive, taxonomic, historical, clinical or institutional relation directly supported by the cited record without claiming a stronger mechanism.
Do not generalize this relation beyond the population, system, period or documentary scope supported by the cited record.
Biliary tract cancer can be reclassified by Precision oncology.
A descriptive, taxonomic, historical, clinical or institutional relation directly supported by the cited record without claiming a stronger mechanism.
Do not generalize this relation beyond the population, system, period or documentary scope supported by the cited record.
VOCE Atlas is a curated knowledge graph. Co-occurrence alone does not create a published relationship. Every connection now carries a semantic class and an inference boundary that remain part of the record alongside its source.